(TSXV: SLG | OTC: SNLGF)
INVESTOR OPPORTUNITY
Why Invest in San Lorenzo Gold?
San Lorenzo Gold offers investors exposure to discovery-stage copper and gold exploration in one of the world’s most mineral-rich and mining-friendly jurisdictions. With strong early drill results, funded for the next phase program, and 100% ownership of a project located near tier-one infrastructure, we’re positioned to deliver significant upside as we advance toward new discoveries.
Flagship Focus - Salvadora
-
100%-owned, 9,000+ ha land package
-
Located just 15 km from Codelco’s El Salvador Mine
-
Five high-priority targets, all supported by drilling and geophysics w. key intercepts including:
-
Cerro Blanco: 153.5 m @ 1.04 g/t Au
-
Caballo Muerto: 112 m @ 1.44 g/t Au
-
Arco de Oro: 102.3 m @ 1.33 g/t Au
-
Funded & Active
San Lorenzo is executing a systematic exploration program, including ongoing geophysics, step-out drilling, and structural analysis across key zones.
Infrastructure & Permitting Advantage
The Salvadora Project benefits from road access, proximity to grid power, and a skilled local workforce. Exploration activities are easily permitted.
Analyst Coverage
San Lorenzo Gold has received coverage from industry research analysts
Please note that any opinions, estimates or forecasts regarding the performance of San Lorenzo Gold made by these analysts are theirs alone and do not represent the opinions, estimates or forecasts of San Lorenzo Gold or its management. By its reference or distribution, San Lorenzo Gold does not imply its endorsement of, or concurrence with, such information, conclusions or recommendations
Capital Structure
AS OF October, 2026
Latest Investor Presentation
October, 2026
Financial Statements
Q1 2026
Financial
Statements
MD&A
Y/E 2025
Audited
Financial
Statements
MD&A
Q3 2025
Financial
Statements
MD&A
Q2 2025
Financial
Statements
MD&A
Q1 2025
Financial
Statements
MD&A
Q2 2026
Financial
Statements
MD&A
Y/E 2024
Audited
Financial
Statements
MD&A
Q3 2024
Financial
Statements
MD&A
Q2 2024
Financial
Statements
MD&A
Q1 2024